On March 8, 2023, Ajit Shetty, Ph.D. informed the Board of Directors of Agile Therapeutics, Inc. that he would not stand for re-election as a Class III director at the upcoming annual meeting of stockholders of the Company for 2023 (the Annual Meeting). The Company does not intend to fill Dr. Shetty's seat on the Board and therefore the size of the Board will be reduced to six directors following the Annual Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3755 USD | +0.13% | -2.21% | -80.74% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
1st Jan change | Capi. | |
---|---|---|
-80.74% | 2.57M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Ajit Shetty Do Not Stand for Re-Election as Class III Director of Agile Therapeutics, Inc